Disse bivirkninger er i samlede placebokontrollerede forsøg rapporteret mindst 1% hyppigere end hos de patienter, som fik placebo b Overordnet begreb
These adverse drug reactions have been reported in the pooled placebo-controlled trials 1% more frequent than in the placebo-treated patients b High Level Term